Monday, June 20, 2016

UPDATE 1-Cat allergy flop sinks high-profile UK biotech Circassia

June 20 (Reuters) - Circassia Pharmaceuticals lost

more than half its value on Monday as its experimental cat

allergy treatment failed in a late-stage trial, dealing a major

blow to the high-profile...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)